Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Evolutions Treatment Center Appoints Darryl Appleton, MD to Medical Director Post
  • USA - English


News provided by

Psynchronous Communications, Inc.

Sep 24, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Darryl Appleton, MD, Medical Director of Evolutions Treatment  Center
Dr. Darryl Appleton, MD, Medical Director of Evolutions Treatment Center

Ft. Lauderdale, FL (PRWEB) September 24, 2014 -- Evolutions Treatment Center is proud to announce the appointment of Darryl Appleton, MD, an internationally recognized expert on sleep disorders, major depression, and mood disorders, as its Medical Director.

Evolutions is a drug and alcohol addiction treatment center known for its fusion of evidence-based therapeutic approaches with some of the very latest thinking and technologies that have proven to assist in the treatment of addiction.

Dr. Appleton consistently remains at the forefront of his field, investigating the newest, ground-breaking treatments as they become available.– Dr. Jeffrey Huttman, Evolutions CEO

Post this

An example of the center's innovative approach to addiction treatment is the emphasis it places on the quality of sleep its patients enjoy. Sleep disturbances are not only known contributors to addiction but also the by product of the disease. Hyposomnia, a sleep disorder in which there is difficulty falling asleep, shorter periods of proper sleep, or a near complete lack of sleep, can dramatically impede an patient's ability to recover in a durable, lasting way by negatively affecting his or her ability to concentrate and absorb the content presented in the therapeutic setting. (Think falling asleep in class.) What’s more, sleep disorders or difficulties can also be directly related to mental health conditions such as anxiety or trauma that may co-occur with the addiction.

"We know from experience that a fully rested Client is better able to focus on the rigorous work to be done in treatment. We consider ourselves very fortunate to have Dr. Appleton, a sleep disorder luminary, join our staff as Medical Director and take ownership of our treatment protocol, " said Dr. Jeffrey Huttman, Evolutions' CEO and Licensed Clinical Psychologist.

Dr. Darryl Appleton is an internationally recognized expert for his research, evaluation and treatment of sleep disorders, major depression, and mood disorders. He has conducted extensive research on the correlation between chronic pain and sleep disorders as well as the effects of anti-depressants on sleep quality. With over 15 years of broad clinical experience assessing and treating thousands of patients with sleep disorders, mood disorders, and addiction and co-occurring disorders, Dr. Appleton has helped thousands of patients find relief.

Dr. Appleton is also considered to be one of the most experienced rTMS (repetitive Transcranial Magnetic Stimulation) practitioners in the U.S. and has become an authority on medical therapies designed to target and treat co-occurring mental health disorders.

"Dr. Appleton is consistently at the forefront of his field, investigating the newest, ground-breaking treatments as they become available. As Medical Director at Evolutions Treatment Center, he will incorporate both established therapies and cutting-edge technologies, including rTMS, into our program, " add Dr. Huttman.

Dr. Appleton is triple-board certified by the American Board of Psychiatry & Neurology (ABPN), the American Board of Independent Medical Examiners (CIME) and the American Board of Sleep Medicine (ABSM.) He is also a fellow at the American Academy of Sleep Medicine (FAASM) and the Royal College of Physicians and Surgeons of Canada (FRCPS(C)). Dr. Appleton completed his medical internship and residency in Psychiatry at the University of Miami and Jackson Memorial Hospital as well as a Fellowship in Sleep Medicine at the University of Toronto. A frequent contributor to leading medical journals, Dr. Appleton is often called upon as an expert for radio and TV, consumer publications and internet forums.

About Evolutions Treatment Center:
Evolutions Treatment Center offers multiple levels of care. Its primary addiction treatment program revolves around a 30-day inpatient stay at the Ft. Lauderdale facility. The center offers extended care options, intensive outpatient aftercare treatment and rTMS to Clients who may benefit from additional treatment. Daily program activities consist of a combination of therapeutic approaches that include one-on-one counseling as well as group therapy, where participants are free to share issues, challenges and advice in a safe, supportive environment.

###

Patrick D'Amico, Psynchronous Communications, Inc., http://www.psynchronous.com, +1 617-686-1983, [email protected]

Modal title

Evolutions Treatment Center Brochure
View PDF
Evolutions Treatment Center Brochure
Evolutions Treatment Center Brochure

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.